Metabolic Syndrome in Mexican Women Survivors of Breast Cancer: A Pilot Study at a General Hospital

Abstract

Introduction:According to developed countries’ studies, in breast cancer survivors there is a high prevalence of metabolic syndrome; however, in Mexico data is lacking about this issue.Goal:To explore if metabolic syndrome occurs in Mexican women survivors of breast cancer.Material and methods:At a second-level general hospital, women with breast cancer with a surviving >2 years were studied. The analysis involved their demographic and anthropometric features, blood pressure measurement, time of surviving, besides fasting blood levels of lipids and glucose.Results:The sample consisted of 100 women; 42% were obese (body mass index ≥30 kg/m2). The sample´s mean age was 60 years with a mean surviving time of 6.5 years. Their mean glucose level was 122 mg/dL and triglycerides 202 mg/dL. There were 33% with blood pressure ≥130/85mm Hg or diagnosis of hypertension. Fifty-seven percent had glucose >99 mg/dL or diagnosis of diabetes mellitus, and 58% had triglycerides >149 mg/dL. Metabolic syndrome occurred in 57% of obese women.Conclusion:Our results suggest that metabolic syndrome occurs in more than 50% of obese Mexican women survivors of breast cancer.

Visceral Adiposity Index in Breast Cancer Survivors: A Case-Control Study

“…Metabolic syndrome, with its various components, is a risk factor for BC recurrence; hence, it may be considered a recurrence predictor and be included as a part of diagnostic standards [ 29 ]. In this research, 59.2% of the survivors and 41.3% of the controls presented metabolic syndrome, which agrees with another study on Mexican women, in which the frequency was 57% in BC survivors and 36% in women without personal BC history [ 30 ].…”

P53 mutation compared with Ki67 marker in metastasis of breast cancer in western Iran

“…Our study in western Iran , recently study [9] and also in eastern Iran [10] show that mean of age in women with breast cancer is around 45 to 50 years, but other recently studies [11,12] , in northwest Iran [13] and in western Iran [14] show that mean of age is around 50 to 70 years. In center of Iran the mean was lower [15] .…”

β-Adrenergic Receptors : New Target in Breast Cancer

“…Powe et al (2010), Melhem et al (2011) and Botteri et al (2013) adjusted the multiple confounding factors. Powe et al (2010) Recently, it's demonstrated that diabetes was an adverse factor for breast cancer (Liao et al, 2011;Melhem et al, 2011;De et al, 2013;Xiao et al, 2014), and so did BMI (Ortiz-Mendoza et al, 2014). A diagnosis of diabetes was associated with a worse OS (P=0.002) but not a worse RFS (P=0.42) (Melhem et al, 2011).…”